Physician profile
Robert Lorino
NPI 1144377722
$1,771.81
in general payments reported to CMS, 2019-2025
8 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $271 · 2021: $141 · 2022: $22.68 · 2023: $186 · 2024: $92.02 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403 · Gift: $137 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.84 |
| Gift | $136.91 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,052.38 | 2019-2025 | Master Series, Lp and Ifit Tubes, Empower-Metal |
| Align Technology, INC. | $477.87 | 2020-2025 | Touch Up, Invisalign |
| Straumann USA LLC | $71.95 | 2025 | |
| Envista Holdings Corporation | $57.96 | 2024-2025 | Spark |
| Biolase, INC. | $40.14 | 2022-2023 | Waterlase Iplus |
| Ormco Corporation | $37.33 | 2021 | |
| Rayner Intraocular Lenses Limited | $17.84 | 2024 | Rayone Spheric, Omidria, Rayone Emv |
| Gc America INC. | $16.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lorino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.